Victory Pharma scores deal with Hi-Tech Pharmacal

Victory Pharma has inked a deal with Hi-Tech Pharmacal for exclusive US commercial license rights to its Naprelan (naproxen sodium) formulation for the treatment of arthritis. The product will be marketed through Victory's physician-based field sales force deployed throughout the US with plans for sales force expansion under way.  


Next Article in Pharmaceutical